Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
- Resource Type
- Article
- Source
- In
Lancet Oncology February 2012 13(2):172-180 - Subject
Primary Research Articles - Language
- ISSN
- 1470-2045